Tauopathies are a class of neurodegenerative diseases characterized by the abnormal aggregation of tau protein in the brain. In Alzheimer's disease, tau proteins become hyperphosphorylated and form neurofibrillary tangles, disrupting neuronal function. This accumulation leads to cell death and is a hallmark of dementia. Unlike other dementias that might involve amyloid plaques, tauopathies primarily focus on the tau protein abnormalities. Understanding tau pathology is crucial for developing targeted therapies aimed at stabilizing tau or preventing its aggregation. Research into tauopathies not only aids in comprehending Alzheimer’s disease but also provides insights into other tau-related disorders, offering broader implications for neurodegenerative disease treatment.
Jun Hua
Johns Hopkins University , United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jacqueline London
Paris Diderot University, FranceSubmit your abstract Today
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neurophysiological change and cognitive response to levetiracetam in Alzheimer disease: Testing the missing mechanistic link
Christopher Hubler, Emergent Neural Systems Institute for Research, United States
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia